Turkish Watchdog Fines AVIXA for Restricting Nasal Spray Supply
The Turkish Competition Board has concluded its investigation into the economic entity…
AstraZeneca and Bristol Myers Squibb Discuss Potential $400 Billion Megadeal
AstraZeneca and Bristol Myers Squibb have held preliminary discussions regarding a potential…
Barrier-Driven Bottlenecks in Latvian Pharmacy Retail
Latvia’s Competition Council (CC) completed a market surveillance study assessing vertical integration…
Court of Appeal Upholds Findings Against Pharma Firms for Exploiting NHS
The Court of Appeal has upheld findings that pharmaceutical companies engaged in…
EU Seeks Feedback on Sanofi’s Commitments
The European Commission has invited comments from interested parties regarding a series…
EU Launches Antitrust Probe into Sanofi Over Alleged Flu Vaccine
The European Commission has escalated its review of the pharmaceutical sector by…
Appeal Court Restores CMA Victory Over Pharma Pricing
The UK Court of Appeal has completely overturned a lower tribunal's intervention,…
Bulgaria Probes Regulatory Barriers in Supply of High-Cost Medicines
The Commission for Protection of Competition has launched an in-depth inquiry into…
Johnson & Johnson Units Settle Tracleer Antitrust Suit for $65 Million
Two subsidiaries of Johnson & Johnson have reached a preliminary $65 million…
Greek Investigation into Radiopharmaceuticals Market
The Hellenic Competition Commission (HCC) has prioritised and assigned to a Commissioner-Rapporteur…
Pharma Merger in Chile Gets Green Light—With Conditions
Chile’s National Economic Prosecutor’s Office (Fiscalía Nacional Económica, FNE) has conditionally approved…
AstraZeneca Anchors Future in China with $15 Billion Investment and Obesity Deal
AstraZeneca has signaled a massive strategic pivot toward China, announcing a landmark…
